SEATTLE, February 22, 2023 -- Adding the oxazolidinone antibiotic sutezolid to a three-drug combination appeared to be safe and effective for people with multidrug-resistant tuberculosis (TB), according to a dose-finding phase II study.

Tuberculosis diagnosis based on cellphone camera photos of chest-rays appeared accurate enough to be of use in resource-poor areas, researchers reported at the virtual meeting of the Radiological Society of North America.

SEATTLE – Pregnant women who are infected with HIV and are at risk of tuberculosis co-infection can undergo isoniazid prevention therapy without causing harm to themselves or their babies, researchers suggested here.

SEATTLE — Patients diagnosed with tuberculosis and human immunodeficiency virus (HIV) may avoid development of sometimes fatal complications when treatment is initiated, researchers reported here.

DURBAN, South Africa, July 21 – Patients diagnosed with tuberculosis as well as HIV do better in combating tuberculosis with an intensified daily regimen rather than intermittent therapy that delivers less medicine, researchers reported here.

BOSTON, February 28 -- A person-by-person tracing process pinpointed transmission of extensively drug-resistant tuberculosis (XDR-TB) to households and hospitals, researchers reported here.

Treatment with the anti-tuberculosis agent isoniazid appeared to protect HIV-infected individuals who live in areas where tuberculosis is highly prevalent -- at least for the short-term, two research teams found.

Children coinfected with HIV and tuberculosis appear to suppress both infections when treated with standard TB regimens and an efavirenz-based HIV regimen, researchers said here at the International AIDS Conference.